Purinergic Signalling

, Volume 6, Issue 4, pp 393–403

Aminoglycoside block of P2X2 receptors heterologously expressed in Xenopus laevis oocytes

  • Eva-Verena Bongartz
  • Jürgen Rettinger
  • Ralf Hausmann
Original Article

DOI: 10.1007/s11302-010-9204-9

Cite this article as:
Bongartz, EV., Rettinger, J. & Hausmann, R. Purinergic Signalling (2010) 6: 393. doi:10.1007/s11302-010-9204-9

Abstract

Aminoglycosides are polycationic antibiotics that have been shown to block a variety of cation channels. The inhibitory effect of externally applied aminoglycosides on P2X2 receptor currents was examined after heterologous expression in Xenopus laevis oocytes using the two-electrode voltage-clamp technique. All of the aminoglycosides tested inhibited the ATP-evoked responses with potencies ranging from 71 μM to 2 mM (IC50 values). The ranked order of potency was streptomycin > gentamicin > neomycin > paromomycin > kanamycin. The inhibition of P2X receptor currents was independent of the ATP concentration used for the activation, which is compatible with a noncompetitive mechanism. The inhibition was voltage-dependent and was reduced at more positive membrane potentials. To examine whether the current block was dependent on the receptor conformation, the aminoglycoside effect on a non-desensitizing P2X2-X1 receptor chimera was analyzed. The results from these measurements suggest that inhibition is caused by an open pore block that locks the P2X receptor chimera in an open nonconducting state from which the agonist dissociation is slow. We also demonstrate that the P2X2-X1 chimera can serve as a tool to directly test whether an antagonist acts competitively or not.

Keywords

Aminoglycoside antibiotics P2X Xenopus oocytes Open pore block 

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Eva-Verena Bongartz
    • 1
  • Jürgen Rettinger
    • 1
  • Ralf Hausmann
    • 2
  1. 1.Department of Biophysical ChemistryMax Planck Institute of BiophysicsFrankfurtGermany
  2. 2.Molecular PharmacologyRWTH Aachen UniversityAachenGermany

Personalised recommendations